Table 2.
Prepregnancy Characteristics | GDM Pregnancies (n = 154) |
Non-GDM Pregnancies (n = 1,655) |
P Value | ||||
No. | % | Mean (SD) | No. | % | Mean (SD) | ||
Race (black) | 75 | 49 | 782 | 47 | 0.75 | ||
Education (high school or less)a | 39 | 25 | 509 | 31 | 0.23 | ||
Smoker (past/current)a | 78 | 51 | 670 | 41 | 0.02 | ||
Oral contraceptive use (current)a | 28 | 18 | 239 | 15 | 0.28 | ||
Family history of diabetes (yes) | 66 | 43 | 439 | 27 | <0.001 | ||
Nulliparous | 81 | 53 | 986 | 60 | 0.07 | ||
Multifetal pregnanciesb | 5 | 3 | 33 | 2 | 0.37 | ||
Hypertensionc | 5 | 4 | 40 | 2 | 0.23 | ||
Metabolic syndrome (NCEP ATP III) | 5 | 3 | 6 | 0.4 | <0.001 | ||
Age, years | 27.4 (5.2) | 27 (5.2) | 0.17 | ||||
Body mass index, kg/m2 | 26.7 (7.5) | 24.1 (5.3) | <0.001 | ||||
Waist circumference, cm | 79.5 (15.5) | 73.7 (10.9) | <0.001 | ||||
Fasting | |||||||
Glucose, mg/dL | 83.9 (10.9) | 81.6 (8.0) | 0.01 | ||||
Insulin, μU/mL | 14.0 (10.1) | 10.8 (6.9) | <0.001 | ||||
Triglycerides, mg/dL | 79.0 (36.6) | 65.6 (32.1) | <0.001 | ||||
HDL-C, mg/dL | 52.1 (14.3) | 56.1 (13.1) | 0.002 | ||||
LDL-C, mg/dL | 110.9 (27.7) | 105.1 (29.4) | 0.008 | ||||
Total cholesterol, mg/dL | 179.0 (30.0) | 174.4 (30.7) | 0.05 | ||||
HOMA-IR | 3.0 (2.4) | 2.2 (1.6) | <0.001 | ||||
Systolic BP, mm Hg | 106.2 (10.6) | 105 (9.5) | 0.12 | ||||
Diastolic BP, mm Hg | 68.0 (7.8) | 66.4 (8.9) | 0.02 | ||||
Mean arterial pressure, mm Hg | 80.7 (8.0) | 79.3 (8.2) | 0.02 |
Abbreviations: BP, blood pressure; CARDIA, Coronary Artery Risk Development in Young Adults; GDM, gestational diabetes mellitus; HDL-C, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment of insulin resistance; LDL-C, low-density lipoprotein cholesterol; NCEP ATP III, National Cholesterol Education Program Adult Treatment Panel III; SD, standard deviation.
Missing variables: education (n = 1); smoking (n = 3); and oral contraceptive use (n = 6).
Multifetal pregnancies during follow-up.
Hypertension before pregnancy (BP, ≥140/90 or taking antihypertensive medication).